Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 on the page.SummaryDifference0.0%

- Check17 days agoChange DetectedNo additions or deletions were detected on the page; the study details and related sections appear unchanged.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision: v3.4.2 has replaced v3.4.1 on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor page/version change that does not modify the study content.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Show glossary and Hide glossary options, and updated labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page shows a minor site revision update: an addition of Revision: v3.3.4 and removal of Revision: v3.3.3; these changes do not affect the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.